Barbara Bober

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Possible changes in glucose metabolism induced by radioligand therapy in patients with neuroendocrine neoplasms.

Possible changes in glucose metabolism induced by radioligand therapy in patients with neuroendocrine neoplasms.

Journal: Endokrynologia Polska

Published: January 01, 2024

Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors-Extended Analysis of Potential Acute and Chronic Complications.

Renal Disturbances during and after Radioligand Therapy of Neuroendocrine Tumors-Extended Analysis of Potential Acute and Chronic Complications.

Journal: International journal of molecular sciences

Published: February 21, 2023

Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms.

Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms.

Journal: Nutrients

Published: December 11, 2022

Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm.

Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm.

Journal: Nuclear medicine review. Central & Eastern Europe

Published: January 19, 2022

Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms-A Preliminary Study.

Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms-A Preliminary Study.

Journal: Journal of clinical medicine

Published: December 14, 2021

THE ROLE OF PET/CT WITH 11C-METHIONINE IN CONTEMPORARY NUCLEAR MEDICINE.

THE ROLE OF PET/CT WITH 11C-METHIONINE IN CONTEMPORARY NUCLEAR MEDICINE.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: November 05, 2020

Recombinant Human Thyrotropin Worsens Renal Cortical Perfusion and Renal Function in Patients After Total Thyroidectomy Due to Differentiated Thyroid Cancer.

Recombinant Human Thyrotropin Worsens Renal Cortical Perfusion and Renal Function in Patients After Total Thyroidectomy Due to Differentiated Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: January 23, 2020

Carcinoid Heart Disease: How to Diagnose and Treat in 2020?

Carcinoid Heart Disease: How to Diagnose and Treat in 2020?

Journal: Clinical Medicine Insights. Cardiology

Published: December 19, 2019

Treatment of neuroendocrine tumors with radio-labeled somatostatin analogues

Treatment of neuroendocrine tumors with radio-labeled somatostatin analogues

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: February 10, 2019

Current treatment of neuroendocrine tumors

Current treatment of neuroendocrine tumors

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: November 19, 2018

WSPÓŁCZESNA DIAGNOSTYKA NOWOTWORÓW NEUROENDOKRYNNYCH Current diagnostics of neuroendocrine tumors

WSPÓŁCZESNA DIAGNOSTYKA NOWOTWORÓW NEUROENDOKRYNNYCH Current diagnostics of neuroendocrine tumors

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: September 30, 2018

Value of multilocus genetic risk score for atrial fibrillation in end-stage kidney disease patients in a Polish population.

Value of multilocus genetic risk score for atrial fibrillation in end-stage kidney disease patients in a Polish population.

Journal: Scientific reports

Published: November 15, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026